Stock · INE406A01037

Aurobindo Pharma

Held by 183 schemes worth ₹13,882 Cr in Sept 2026.

Schemes holding Aurobindo Pharma(Sept 2012 – Sept 2026)

Schemes holding Aurobindo Pharma in Sept 2026. Tick up to 2 to plot them.
Plot183 schemes · ₹ Cr
2,231
1,112
820
786
712
670
508
502
452
361
330
301
293
253
251
201
201
174
169
167
162
155
151
149
132
118
116
113
105
96.5
83.5
83.3
83.1
82.9
81.4
74
72.5
70.8
63.5
61.1
49.5
48.7
45.5
43.7
42.4
42.4
41.8
40.1
34.7
30.6
  • HDFC Mid Cap Fund
  • quant ELSS Tax Saver Fund
Market value of Aurobindo Pharma in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthHDFC Mid Cap Fundquant ELSS Tax Saver Fund
Sept 2025₹1,446 Cr₹561 Cr
Oct 2025₹1,520 Cr₹589 Cr
Nov 2025₹1,637 Cr₹635 Cr
Dec 2025₹1,579 Cr₹612 Cr
Jan 2026₹1,612 Cr₹810 Cr
Feb 2026₹1,629 Cr₹819 Cr
Mar 2026₹1,741 Cr₹875 Cr
Apr 2026₹1,854 Cr₹932 Cr
May 2026₹1,903 Cr₹949 Cr
Jun 2026₹2,107 Cr₹1,050 Cr
Jul 2026₹2,109 Cr₹1,051 Cr
Aug 2026₹2,291 Cr₹1,142 Cr
Sept 2026₹2,231 Cr₹1,112 Cr
Fig. 1.Market value of Aurobindo Pharma in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

29 fund houses% of total
QUANT
1834.03
SBI
1624.29
HDFC
1022.34
Nippon
93.22
Kotak
112.82
Old Bridge
31.93
Aditya Birla
71.80
Mirae
161.64
BOI AXA
81.19
Axis
81.10
Other fund houses
775.65

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Aurobindo Pharma(Oct 2025 – Sept 2026)

Schemes buying and selling Aurobindo Pharma. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.